Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Hetzer Medical Indonesia Tbk. (MEDS) vs Sinergi Multi Lestarindo Tbk. (SMLE) Price & Performance

Hetzer Medical Indonesia Tbk.Trade
Sinergi Multi Lestarindo Tbk.Trade

Price performance (Past 24H)

Key statistics

Hetzer Medical Indonesia Tbk. vs Sinergi Multi Lestarindo Tbk. — how do they compare? Hetzer Medical Indonesia Tbk. trades at Rp86 (market cap 139.06B, 51.66M 24h volume), while Sinergi Multi Lestarindo Tbk. trades at Rp185 (market cap 444.68B, 19.41M 24h volume). The key difference: Sinergi Multi Lestarindo Tbk. is far larger — about 3.2× Hetzer Medical Indonesia Tbk.'s market cap, and Hetzer Medical Indonesia Tbk. is more actively traded (51.66M versus 19.41M). Which is the better fit depends on your goals.

MEDSSMLE
Market Cap
139.06B444.68B
Volume
51.66M19.41M
Lot
516.62K194.13K
Turnover
4.44B3.66B
Average Price
85.97188.72
Value
4.44B3.66B
Indicative Equilibrium Price
86185
Indicative Equilibrium Volume
9.62K388

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

MEDS
View details
SMLE
View details

About Hetzer Medical Indonesia Tbk.

PT Hetzer Medical Indonesia Tbk (the Company) was established based on Notarial Deed of Cahya Suryana, S.H., Notary in Bandung, No. 12 dated December 31, 2010.

Read more on MEDS

About Sinergi Multi Lestarindo Tbk.

PT Sinergi Multi Lestarindo Tbk (the Company) was established based on Deed No. 5 dated March 18, 2013 by Aryadi, S.H., M.Kn., Notary in Tangerang. PT Sinergi Asia Corporindo is the parent entity of the Company and Siu Min is the ultimate beneficiary owner of the Company.

Read more on SMLE